Home

zoom virgin Acord table noac high risk bleeding Poleiala speriind Face

Interpreting Safety Results of NOACs Based on Bleeding Risk | Thrombosis  Adviser
Interpreting Safety Results of NOACs Based on Bleeding Risk | Thrombosis Adviser

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific  Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation -  Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library

Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders  in Pharmaceutical Business Intelligence (LPBI) Group
Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Comparison of upper gastrointestinal bleeding risk in users of warfarin...  | Download Scientific Diagram
Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram

NOAC FAQs – Mitigation and management of the bleeding risk #2
NOAC FAQs – Mitigation and management of the bleeding risk #2

Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure  And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes

Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of  the Week - ScienceDirect
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in  Asians With Nonvalvular Atrial Fibrillation
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With  Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar
PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar

PDF] Evaluation of bleeding in patients receiving direct oral  anticoagulants | Semantic Scholar
PDF] Evaluation of bleeding in patients receiving direct oral anticoagulants | Semantic Scholar

Periprocedural management of patients receiving a vitamin K antagonist or a  direct oral anticoagulant requiring an elective procedure or surgery -  Spyropoulos - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online  Library
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery - Spyropoulos - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library

Safety of new oral anticoagulant drugs: a perspective - Juan Antonio  Vílchez, Pilar Gallego, Gregory Y.H. Lip, 2014
Safety of new oral anticoagulant drugs: a perspective - Juan Antonio Vílchez, Pilar Gallego, Gregory Y.H. Lip, 2014

Oral anticoagulants in extremely-high-risk, very elderly (>90 years)  patients with atrial fibrillation - Heart Rhythm
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation - Heart Rhythm

Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues  in association with Arrhythmia & Electrophysiology Review | AER Journal
Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | AER Journal

Comparison of each NOAC and warfarin in risk of major bleeding in... |  Download Scientific Diagram
Comparison of each NOAC and warfarin in risk of major bleeding in... | Download Scientific Diagram

Comparison of the NOACs -Pharmacokinetics. | Download Table
Comparison of the NOACs -Pharmacokinetics. | Download Table

Anticoagulation highlights from the ESC - The British Journal of Cardiology
Anticoagulation highlights from the ESC - The British Journal of Cardiology

Schemes of discontinuation of NOACs. | Download Table
Schemes of discontinuation of NOACs. | Download Table

Table 3 from Gastrointestinal bleeding in patients on novel oral  anticoagulants: Risk, prevention and management | Semantic Scholar
Table 3 from Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management | Semantic Scholar

Frontiers | Tailored Practical Management of Patients With Atrial  Fibrillation: A Risk Factor-Based Approach
Frontiers | Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach

Emergency care of patients receiving non-vitamin K antagonist oral  anticoagulants - ScienceDirect
Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants - ScienceDirect

Cancers | Free Full-Text | Multiple Myeloma and Thrombosis: Prophylaxis and  Risk Prediction Tools | HTML
Cancers | Free Full-Text | Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools | HTML

Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in  the Acute Care and Periprocedural Setting: A Scientific Statement From the  American Heart Association | Circulation
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association | Circulation